The
rodent Crry protein regulates a branch of the immune system called
the complement system, which helps destroy foreign material such
as infectious organisms. Crry prevents complement proteins called
C3 and C4 from marking cells for immune-system destruction.
Molina's
team found that mice that should have given birth to some offspring
lacking Crry had smaller litters instead. When the researchers
examined similar mice during their 19-day gestation period, they
detected complement activity in Crry-free embryos. On the seventh
day, outer embryo cells and cells of the developing placentas
bore activated complement proteins. Moreover, immune cells called
neutrophils had invaded these complement-bound tissues and were
entering the Crry-free embryo.
Similar
embryos analyzed on the ninth and 10th days of gestation also
were undersized, as were the placentas, which are partially derived
from embryonic tissue. By the 10th day, there were fewer embryos
that lacked Crry. This suggested that the protein's absence had
permitted the immune system to destroy embryos, leading to miscarriage.
Molina's
team tested this theory by examining mouse embryos lacking both
Crry and complement factor C3, which helps activate most components
of the complement system. Without C3, Crry's absence had no effect
Ð all the embryos developed normally.
Molina
suggests that mouse embryos missing only Crry become starved of
nutrients as the placenta is destroyed. "It appears that
the mother has to constantly control complement activation Ð
especially on the surface of the placenta Ð for an embryo
to survive," he says.
Two
placental proteins perform Crry's duties in humans: decay accelerating
factor and membrane cofactor protein. Their role in miscarriage
has not been addressed previously, though. "Using the mouse
studies as a framework, we can jump to human studies and see whether
miscarriages in women also involve complement regulation,"
Molina says.
The
effort will focus on women who have autoimmune diseases such as
lupus erythematosus and multiple miscarriages. Molina's team and
investigators elsewhere will try to determine whether such women
have diminished levels of the Crry-like regulatory proteins and
thus might benefit from supplemental therapy. Molina also will
study animal models to determine how inadequate activation of
C3 in the absence of Crry influences diseases such as lupus.
This
story has been adapted from a news release issued by Washington
University School Of Medicine, medinfo.wustl.edu.
Next - Back
to Immune System Boosting Research